FAGI.US Full Alliance Group Inc

Healthcare Pharmaceuticals USA Stocks
0.0032 USD
Close of Nov 13, 2026
0.0024 0.0750
Market cap
USD 435K
P/E
-
P/B
-
ROE
0.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is FAGI.US undervalued?

Graham number

The Graham number of Full Alliance Group Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Full Alliance Group Inc fundamental analysis

No fundamental analysis for Full Alliance Group Inc yet.

Full Alliance Group Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Full Alliance Group Inc

Full Alliance Group, Inc., through subsidiaries, engages in nutraceuticals, supplement manufacturing, health-related services, fintech, and blockchain product initiatives. The company was formerly known as Beverly Hills Group, Inc. and changed its name to Full Alliance Group, Inc. in April 2017. Full Alliance Group, Inc. was founded in 2000 and is based in Oldsmar, Florida.

Full company profile